Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 9, 2013

Two Pathways Found through which Chromosomes are Rearranged

  • Biologists from the University of Texas Health Science Center at San Antonio reported yesterday that they have identified two pathways through which chromosomes are rearranged in mammalian cells. Their report, published in Nature, also noted that these types of changes are associated with some cancers and inherited disorders in people.

    "Our finding provides a target to prevent these rearrangements, so we could conceivably prevent cancer in some high-risk people," said senior author Edward P. (Paul) Hasty, D.V.M.

    The two pathways rearrange chromosomes by recombining DNA repeats, sections of DNA that are duplicated. Repeats are naturally found in the genome.

    Both pathways are important for the synthesis of DNA. "Therefore, we propose that chromosomal rearrangements occur as DNA is being synthesized," Dr. Hasty said.

    The experiments were conducted with mouse embryonic stem cells grown in tissue culture. The team measured the incidence of DNA repeats recombining in normal cells. This is called "repeat fusion." The scientists then looked for incidence of repeat fusion in cells affected by several genetic mutations.

    In the paper, entitled, “Two replication fork maintenance pathways fuse inverted repeats to rearrange chromosomes,” indicated that the spontaneously fused repeats generated unstable chromosomal rearrangements: “Gamma-radiation induced a [Bloom syndrome mutated]-regulated pathway that selectively fused identical, but not mismatched, repeats. By contrast, ultraviolet light induced a RAD18-dependent pathway that efficiently fused mismatched repeats.”

    These large, complicated rearrangements involved DNA repeats on multiple chromosomes. The discovery provides target to potentially halt the process, prevent cancers. "We hope the new findings will help us better understand the mechanisms that cause chromosomal instability, which causes some cancers in people," Dr. Hasty said.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »